LRRN3 polyclonal (C-term), anti-human
€0.00
In stock
SKU
AC-AP11970b
Catalog Number: AC-AP11970b
Size: 80 µl, 400 µl
Isotype: Rabbit IgG
Clone Name: RB20586
Applications: WB
Datasheet
Request Information
Size: 80 µl, 400 µl
Isotype: Rabbit IgG
Clone Name: RB20586
Applications: WB
Datasheet
Request Information
Background:
LRRN3 is a single pass type I membrane protein. It contains 1 fibronectin type III domain, 1 Ig like C2 type (immunoglobulin like) domain and 12 LRR (leucine rich) repeats. The function of the LRRN3 protein remains unknown.
Other Names:
Leucine-rich repeat neuronal protein 3, Neuronal leucine-rich repeat protein 3, NLRR-3, LRRN3
Target/Specificity:
This LRRN3 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 596-623 amino acids from the C-terminal region of human LRRN3.
Antigen Region:
596-623
Antigen Type: Synthetic Peptide
Gene Name: LRRN3
Gene ID: 54674
Primary Accession: Q9H3W5
NCBI Accession: NP_001093128.1;NP_001093130.1;NP_060804.3
Other Accession: NP_060804
Format: Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.
LRRN3 is a single pass type I membrane protein. It contains 1 fibronectin type III domain, 1 Ig like C2 type (immunoglobulin like) domain and 12 LRR (leucine rich) repeats. The function of the LRRN3 protein remains unknown.
Other Names:
Leucine-rich repeat neuronal protein 3, Neuronal leucine-rich repeat protein 3, NLRR-3, LRRN3
Target/Specificity:
This LRRN3 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 596-623 amino acids from the C-terminal region of human LRRN3.
Antigen Region:
596-623
Antigen Type: Synthetic Peptide
Gene Name: LRRN3
Gene ID: 54674
Primary Accession: Q9H3W5
NCBI Accession: NP_001093128.1;NP_001093130.1;NP_060804.3
Other Accession: NP_060804
Format: Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.
| Is Featured? | No |
|---|
Write Your Own Review